Scott M. Pittman - 31 Dec 2019 Form 5 Insider Report for Nuo Therapeutics, Inc. (AURX)

Role
Director, 10%+ Owner
Signature
/s/ David E. Jorden, attorney-in-fact
Issuer symbol
AURX
Transactions as of
31 Dec 2019
Transactions value $
$0
Form type
5
Filing time
26 Apr 2022, 21:20:21 UTC
Next filing
26 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AURX Warrants to purchase Common Stock Award $0 +15,000 $0.000000 15,000 15 Nov 2019 Common Stock 15,000 $0.4000 Direct F1, F2
transaction AURX Warrants to purchase Common Stock Award $0 +30,000 +200% $0.000000 45,000 06 Dec 2019 Common Stock 30,000 $0.4000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction approved by Board of Directors of Issuer and Non-Employee Directors
F2 Acquired in connection with Note Purchase Agreement dated as of November 15, 2019